Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study

Pediatric Allergy and Immunology

Volumn 15, Issue 4, 2004, Pages 359-364

  Stelmach, Iwona ^a   Majak, Pawel ^a   Jerzynska, Joanna ^a   Stelmach, Wlodzimierz ^b   Kuna, Piotr ^c  

^a M Curie Hospital   (Poland)

^b Regional Health Authority   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Asthma control; Asthma treatment; Bronchial hyper reactivity; Lung function

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; HOUSE DUST ALLERGEN; MONTELUKAST; NEDOCROMIL; TRIAMCINOLONE;

ADOLESCENT; ADULT; ALLERGIC ASTHMA; ARTICLE; ASTHMA; BLOOD CELL COUNT; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL ANALYSIS; SYMPTOM;

ACETATES; ADMINISTRATION, INHALATION; ADOLESCENT; ADRENERGIC BETA-AGONISTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; EOSINOPHILS; FEMALE; HUMANS; MALE; NEDOCROMIL; QUINOLINES; RESPIRATORY FUNCTION TESTS; TRIAMCINOLONE;

EID: 4143071397     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2004.00153.x     Document Type: Article

References (35)

1. FERGUSON AC, WONG F. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosinophils in broncholavage fluid. Chest 1989: 96: 988-91.
2. ZIMMERMAN B, LANNER A, ENANOBER I. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993: 23: 564-70.
3. BOUSQUET J, CORRIGAN CJ, VENGE P. Peripheral blood markers: evaluation and inflammation in asthma. Eur Respir J 1998: 26: 42-8.
4. GRUTTERS JC, BRINKMAN L, ASLANDER MM, BOSCH JMM, KOENDERMAN L, LAMMERS JWJ. Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics. Eur Respir J 1999: 14: 915-22.
5. American Thoracic Society Workshop. Medical Section of the American Lung Association. Immunobiology of asthma and rhinitis. Pathogenic factors and therapeutic options. Am J Respir Crit Care Med 1999: 160: 1778-87.
6. National Asthma Education and Prevention Program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda (MD): NIH/National Heart, Lung, and Blood Institute; April 1997. Publication No. 97-4051.
7. HELMS PJ. 'Real world' pragmatic clinical trials: what are they and what do they tell us? Pediatr Allergy Immunol 2002: 13: 4-9.
8. STELMACH I, JERZYŃSKA J, KUNA P. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy 2002: 32: 264-9.
9. STELMACH I, JERZYŃSKA J, KUNA P. A randomised, double-blind trial of the effect of treatment with montelukast on bronchial hyperresponsiveness and serum ECP, sIL-2R, IL-4, and sICAM-1 in children with asthma. J Allergy Clin Immunol 2002: 109: 11-17.
10. SANTANELLO NC, BARBER BL, REISS TF, et al. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997: 10: 646-51.
11. JUNIPER EF, GUYATT GH, FEENY DH, FERRIE PJ, GRITH LE, TOWNSEND M. Measuring quality of life in children with asthma. Qual Life Res 1996: 5: 35-46.
12. CRAPO RO, HANKINSON JL, IRVIN C. Standarization of spirometry. Am J Respir Crit Care Med 1995: 152: 1107-36.
13. COCKROFT DW, MURDOCK KY, MINK JT. Determination of histamine PC20. Chest 1983: 54: 505-6.
14. MALMSTROM K, RODRIGUEZ-GOMEZ G, GUERRA J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999: 130: 487-95.
15. The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000: 343:1054-63.
16. NARAYANAN S, EDELMAN JM, BERGER ML, MARKSON LE. Asthma control and patient satisfaction among early pediatric users of montelukast. J Asthma 2002: 39: 757-65.
17. ADELSBERG J, PHILIP G, LAFORCE CF, et al. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003: 90: 214-22.
18. O'BYRNE PM, ISRAEL E, DRAZEN JM. Antileukotrienes in treatment of asthma. Ann Intern Med 1997: 127: 472-80.
19. HORWITZ RJ, MCGILL KA, BUSSE WW. The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care 1998: 157: 1363-71.
20. SUISSA S, DENNIS R, ERNST P, SHEEHY O, WOOD-DAUPHINEE S. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. Ann Intern Med 1997: 126: 177-83.
21. WEINBERG EG, NAYA I. Treatment preferences of adolescent patients with asthma. Pediatr Allergy Immunol 2000: 11: 49-55.
22. GARCIA-MARCOS L, SCHUSTER A. New perspectives for asthma treatment: anti-leukotriene drugs. Pediatr Allergy Immunol 1999: 10: 77-88.
23. LANZ MJ, EISENLOHR C, LLABRE MM, TOLEDO Y, LANZ MA. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast. Ann Allergy Asthma Immunol 2001: 87: 283-8.
24. KIPS JC, O'CONNOR BJ, INMAN MD, SVENSSON K, PAUWELS RA, O'BYRNE PM. A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000: 161: 996-1001.
25. STELMACH I, JERZYŃSKA J, KUNA P. Markers of allergic inflammation in peripheral blood of children with asthma after treatment with inhaled triamcinolone acetonide. Ann Allergy Asthma Immunol 2001: 87: 319-26.
26. KANNISTO S, VOUTILAINEN R, REMES K, KORPPI M. Efficacy and safety of inhaled steroid and cromone treatment in school-age children: a randomized pragmatic pilot study. Pediatr Allergy Immunol 2002: 13: 24-30.
27. KONIG, P. The effects of cromolyn sodium and nedocromil sodium in early asthma prevention. J Allergy Clin Immunol 2000: 105: 575-81.
28. KORPPI M, REMES K. Asthma treatment in school children: lung function in different therapeutic groups. Acta Paediatr 1996: 85: 190-4.
29. North American Tilade Study Group. A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma. Chest 1990: 97: 1299-306.
30. AALBERS R, KAUMAN HF, GROEN H, KOETER GH, DE MONCHY JGR. The effect of nedocromil sodium on the early and late reaction and allergen-induced bronchial hyperresponsiveness. J Allergy Clin Immunol 1991: 87: 993-1001.
31. SCHWARTZ HJ, BLUMENTHAL M, BRADY R, et al. A comparative study of the clinical efficacy of nedocromil sodium and placebo: how does cromolyn sodium compare as an active control treatment? Chest 1996: 109: 945-52.
32. EDWARDS AM, LYONS J, WEINBERG E, et al. Early use of inhaled nedocromil sodium in children following an acute episode of asthma. Thorax 1999: 54: 308-15.
33. MANOLITSAS ND, WANG J, DEVALIA JL, TRIGG CJ, MCAULAY AE, DAVIES RJ. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am J Respir Crit Care Med 1995: 151: 1925-30.
34. DEVALIA JL, RUSZNAK C, ABDELAZIZ MM, DAVIES RJ. Nedocromil sodium and airway inflammation in vivo and in vitro. J Allergy Clin Immunol 1996: 98: S51-S57.
35. ABDELAZIZ MM, DEVALIA JL, KHAIR OA, et al. The effect of nedocromil sodium on human airway epithelial cell-induced eosinophil chemotaxis and adherence to human endothelial cell in vitro. Eur Respir J 1997: 10: 851-7.